We are live on ! Find out more
IEIH

iShares Evolved U.S. Innovative Healthcare ETF

Delisted

IEIH was delisted on the 22nd of August, 2022.

1 hedge funds and large institutions have $900K invested in iShares Evolved U.S. Innovative Healthcare ETF in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

75% less capital invested

Capital invested by funds: $3.58M → $900K (-$2.68M)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$880K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.58M
Name Holding Trade Value Shares
Change
Change in
Stake
VF
1
Virtu Financial
New York
$900K +$880K +36,526 New
BlackRock
2
BlackRock
New York
-$3.58M -150,000 Closed

IEIH Hedge Fund Activity: Q2 2018 in Review

1 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q2 2018, worth a combined $900K — down 75% from $3.58M a quarter earlier.

Fund positioning in IEIH was balanced in Q2 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $880K. The largest seller was BlackRock, exiting entirely with an estimated $3.58M sold.

  • 1 institutional investor held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $900K of iShares Evolved U.S. Innovative Healthcare ETF stock for Q2 2018, down 75% quarter-over-quarter.
  • 1 fund opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q2 2018 and 1 closed out, a net change of 0 holders.
  • The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q2 2018 was Virtu Financial, an estimated $880K added.
  • The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q2 2018 was BlackRock, an estimated $3.58M sold.

Based on aggregated 13F filings for Q2 2018.